49.14

0.61% 0.30

Soleno Therapeutics Inc (SLNO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Soleno Therapeutics Inc stock is traded at $49.14, with a volume of 365.66K. It is up +0.61% in the last 24 hours and up +7.04% over the past month. Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Previous Close:

$48.84

Open:

$48.9

24h Volume:

365.66K

Relative Volume:

0.21

Market Cap:

$2.64B

Revenue:

Net Income/Loss:

$-38.99M

P/E Ratio:

-16.40

EPS:

-2.9966

Net Cash Flow:

$-24.94M

1W Performance:

-0.22%

1M Performance:

+7.04%

6M Performance:

-41.62%

1Y Performance:

+9.76%

1-Day Range:

$48.51

$49.74

1-Week Range:

$47.01

$49.74

52-Week Range:

$41.50

$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name

Soleno Therapeutics Inc

Sector

Healthcare (1130)

Industry

Biotechnology (632)

Phone

650-213-8444

Address

100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA

Employee

152

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

SLNO's Discussions on Twitter

Compare SLNO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLNO Soleno Therapeutics Inc	49.14	2.62B	0	-38.99M	-24.94M	-2.9966
VRTX Vertex Pharmaceuticals Inc	462.99	116.51B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.71	82.52B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.69	52.67B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	849.95	52.08B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.42	37.70B	447.02M	-1.18B	-906.14M	-6.1812

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-18-25	Initiated	Wolfe Research	Outperform
Oct-07-25	Initiated	Goldman	Buy
Aug-20-25	Initiated	Wells Fargo	Overweight
Jun-23-25	Initiated	TD Cowen	Buy
Mar-05-25	Resumed	Stifel	Buy
Dec-02-24	Reiterated	Robert W. Baird	Outperform
Dec-02-24	Reiterated	Stifel	Buy
Sep-03-24	Initiated	H.C. Wainwright	Buy
May-10-24	Initiated	Robert W. Baird	Outperform
Feb-05-24	Initiated	Piper Sandler	Overweight
Jan-23-24	Initiated	Stifel	Buy
Nov-21-23	Resumed	Guggenheim	Buy
Sep-29-20	Initiated	Guggenheim	Buy
Jan-10-20	Initiated	Craig Hallum	Buy
Dec-23-19	Initiated	Oppenheimer	Outperform
Feb-13-18	Reiterated	Maxim Group	Buy

View All

Soleno Therapeutics Inc Stock (SLNO) Latest News

Dec 23, 2025

Soleno Therapeutics (NASDAQ:SLNO) Share Price Crosses Below 50-Day Moving AverageWhat's Next? - MarketBeat

Dec 23, 2025

Soleno Therapeutics Inc (NASDAQ:SLNO) Nasdaq today Biopharma Niche Growth - Kalkine Media

Dec 23, 2025

Dec 22, 2025

Precision Trading with Soleno Therapeutics Inc. (SLNO) Risk Zones - Stock Traders Daily

Dec 22, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Soleno Therapeutics, Inc. (SLNO) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Dec 22, 2025

Dec 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Soleno Therapeutics, Inc. (SLNO) Investors to Inquire about Securities Investigation - ACCESS Newswire

Dec 21, 2025

Is Soleno Therapeutics (NASDAQ:SLNO) Using Debt Sensibly? - 富途牛牛

Dec 21, 2025

Fed Meeting: What momentum indicators show for Soleno Therapeutics Inc. stock2025 Market WrapUp & Weekly Return Optimization Alerts - Улправда

Dec 21, 2025

Dec 20, 2025

Will Soleno Therapeutics Inc. stock see insider buyingQuarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда

Dec 20, 2025

Is Soleno Therapeutics Inc. stock affected by interest rate hikesIPO Watch & Short-Term Trading Opportunity Alerts - ulpravda.ru

Dec 20, 2025

Why Soleno Therapeutics Inc. stock could rally in 2025Dollar Strength & Weekly Top Stock Performers List - Улправда

Dec 20, 2025

Dec 19, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire

Dec 19, 2025

Can Soleno Therapeutics Inc. stock hit record highs again2025 Year in Review & Fast Gaining Stock Reports - DonanımHaber

Dec 19, 2025

Dec 18, 2025

How Soleno Therapeutics Inc. stock performs in weak economyPortfolio Risk Report & Low Drawdown Momentum Trade Ideas - Улправда

Dec 18, 2025

Rate Hike: What momentum indicators show for Soleno Therapeutics Inc. stockJuly 2025 Technicals & Community Verified Trade Signals - ulpravda.ru

Dec 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Stockholders to Reach Out - ACCESS Newswire

Dec 18, 2025

Dec 16, 2025

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeu - GuruFocus

Dec 16, 2025

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses - PR Newswire

Dec 16, 2025

Dec 15, 2025

Reassessing Soleno Therapeutics (SLNO) Valuation After Wolfe Research’s Confidence Boost and Improving Fundamentals - Sahm

Dec 15, 2025

Soleno Therapeutics (SLNO) Valuation Check After Wolfe Research’s Optimistic New Coverage and Stock Pop - Yahoo Finance

Dec 15, 2025

How Soleno Therapeutics' Audit Committee Leadership Transition At Soleno Therapeutics (SLNO) Has Changed Its Investment Story - Yahoo Finance

Dec 15, 2025

34,840 Shares in Soleno Therapeutics, Inc. $SLNO Purchased by Castleark Management LLC - MarketBeat

Dec 15, 2025

Dec 14, 2025

Soleno Therapeutics Gains Momentum Following Wolfe Research Favorable Rating - timothysykes.com

Dec 14, 2025